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Comparative profiling of skeletal muscle models reveals heterogene-
ity of transcriptome and metabolism. Am J Physiol Cell Physiol 318:
C615–C626, 2020. First published December 11, 2019; doi:10.1152/
ajpcell.00540.2019.—Rat L6, mouse C2C12, and primary human
skeletal muscle cells (HSMCs) are commonly used to study biological
processes in skeletal muscle, and experimental data on these models
are abundant. However, consistently matched experimental data are
scarce, and comparisons between the different cell types and adult
tissue are problematic. We hypothesized that metabolic differences
between these cellular models may be reflected at the mRNA level.
Publicly available data sets were used to profile mRNA levels in
myotubes and skeletal muscle tissues. L6, C2C12, and HSMC myo-
tubes were assessed for proliferation, glucose uptake, glycogen syn-
thesis, mitochondrial activity, and substrate oxidation, as well as the
response to in vitro contraction. Transcriptomic profiling revealed that
mRNA of genes coding for actin and myosin was enriched in C2C12,
whereas L6 myotubes had the highest levels of genes encoding
glucose transporters and the five complexes of the mitochondrial
electron transport chain. Consistently, insulin-stimulated glucose up-
take and oxidative capacity were greatest in L6 myotubes. Insulin-
induced glycogen synthesis was highest in HSMCs, but C2C12
myotubes had higher baseline glucose oxidation. All models re-
sponded to electrical pulse stimulation-induced glucose uptake and
gene expression but in a slightly different manner. Our analysis
reveals a great degree of heterogeneity in the transcriptomic and
metabolic profiles of L6, C2C12, or primary human myotubes. Based
on these distinct signatures, we provide recommendations for the
appropriate use of these models depending on scientific hypotheses
and biological relevance.
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INTRODUCTION
Skeletal muscle is one of the largest organs in the body and
plays an important role in locomotion and whole-body meta-
bolic homeostasis. The formation of myofibers during myo-
genesis and muscle repair involves the activation of progenitor
cells, which proliferate as mononuclear myoblasts and eventu-
ally fuse to form multinucleated myotubes (10). Adult skeletal
muscle also comprises nerves, vasculature, smooth muscle
cells, fibroblasts, and resident immune cells, which all contrib-
ute to the different functions fulfilled by muscle. This complex
arrangement makes it difficult to decipher the specific contri-
bution of muscle cells to physiological outcomes and limits the
methods available to study intramyocellular processes in vivo
(11). Molecular insights can, however, be obtained from in
vitro models of skeletal muscle, such as immortalized C2C12
cells derived from thigh muscle of mice (55) and L6 cells
isolated from cultures of thigh muscle of newborn rats (36).
The L6 cell line has been extensively used in metabolic studies
(17, 51, 53), and several modified clones have been developed,
such as the L6-GLUT4myc cells that were engineered to
express a labeled, insulin-responsive glucose transporter 4
(GLUT4) (53). Cultured primary myoblasts from human biop-
sies have also been developed (6) and are now widely used in
metabolic studies.
Rat L6, mouse C2C12, and human primary muscle cells are
the most commonly used cellular models to study skeletal
muscle in vitro (1). Increasingly, researchers use primary
human cells as a model system that has closer relevance to
human health, but comparative studies of C2C12, L6, and
primary human muscle cells are scarce. These models exhibit
striking differences in response to diverse stimuli that influence
substrate metabolism (25, 35, 37, 50), such that C2C12 cells
are generally used to assess the effects of contraction/exercise-
like stimuli (29, 47) and muscle atrophy (27, 45), and L6 cells
and human primary myotubes are used for the study of metab-
olism and nutritional cues (20, 34, 51). Despite the vast amount
of experimental data on their metabolic properties, the tran-
scriptional variation between these models is unknown. We
hypothesized that differences in the transcriptomic landscape
may account for the diverse metabolic and contractile pheno-
types associated with these models. To address this, we com-
pared the transcriptional variation between adult skeletal mus-
cle and cell cultures using publicly available data sets, and we
associated gene-expression changes with the relative response
of each cell/tissue type to measurements of proliferation, glu-
cose uptake, mitochondrial activity, substrate oxidation, and
response to in vitro contraction.
METHODS
Transcriptomic data acquisition and processing. Publicly available
data from myotubes and skeletal muscle tissues were selected from
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the Gene Expression Omnibus database (Supplemental Table S1; see
https://doi.org/10.5281/zenodo.1246757). The variability in tran-
scripts due to the use of different arrays was accounted for by
including samples from both cells and tissues for each platform and
using ranked statistics. Because human, rat, and mouse samples were
processed using species-specific arrays, we cannot exclude the possi-
bility that species-specific differences identified in our analysis may
be due to interarray variability. We selected platforms in which both
skeletal muscle cells and tissue samples for human (GPL570,
GPL6244, GPL17586), rat (GPL1355, GPL22740, GPL14746), and
mouse (GPL81, GPL1261, GPL17400) were available. Only samples
corresponding to untreated, control conditions were kept for the
analysis. Skeletal muscle tissue samples were selected from different
anatomical locations so that the analysis included a mix of oxidative
and glycolytic fibers. Raw files were downloaded, and robust
multi-array normalization was performed in unison for all samples
from the same platform. For each human Ensembl annotation, the
rat and mouse orthologs were found using the R package BioMart,
and the arrays were merged based on the human Ensembl annota-
tion. The database was then aggregated according to the official
human gene symbol. When multiple Ensembl annotations were
found for a single gene symbol, an average was calculated. Quan-
tile normalization, median centering, and statistics were performed
using the R package limma. Gene ontology analysis was carried
out in clusterProfiler (56) on genes that passed a false discovery
rate  0.05. Code for the analysis is available at https://github.
com/NicoPillon/Muscle_Models_Profiling.
Culture and differentiation of rat L6 muscle cells. Rat L6 muscle
cells were obtained from the American Type Culture Collection and
grown in minimum essential medium Eagle  modification (AMEM;
5.5 mM glucose; no. 22571; Gibco), supplemented with 100 U/mL
penicillin, 100 g/mL of streptomycin, and 0.25 g/mL of ampho-
tericin B (no. 15240; Gibco) and 10% fetal bovine serum (FBS; no.
F7524; Sigma-Aldrich). Subculturing was done by trypsinization, and
cells were diluted to 105 cells/mL and seeded in plates. After ~2 days,
when the cells reached 90% confluence, differentiation was induced
by switching to AMEM, supplemented with 100 U/mL penicillin, 100
g/mL streptomycin, and 0.25 g/mL amphotericin B and 2% horse
serum. Differentiation was monitored under the microscope, and cells
were used for experiments after 4–6 days. The absence of myco-
plasma contamination was routinely confirmed by PCR.
Culture and differentiation of mouse C2C12 muscle cells. Mouse
C2C12 muscle cells were obtained from the American Type Culture
Collection (ATCC CRL-1772) and grown in AMEM, supplemented
with 100 U/mL penicillin, 100 g/mL of streptomycin, and 0.25
g/mL of amphotericin B and 10% fetal bovine serum. Subculturing
was done by trypsinization, and cells were diluted to 2  105
cells/mL, and seeded in plates. A day after the cells reached 100%
confluence, differentiation was induced by switching to AMEM,
supplemented with 100 U/mL penicillin, 100 g/mL of streptomycin,
and 0.25 g/mL of amphotericin B and 2% horse serum. Differenti-
ation was monitored under the microscope, and cells were used for
experiments after 6–8 days. The absence of mycoplasma contamina-
tion was routinely confirmed by PCR.
Culture and differentiation of primary human skeletal muscle cells.
Primary cells were isolated from vastus lateralis skeletal muscle
biopsies derived from 12 healthy men (age: 50.4 10 yr; body mass
index: 22.9 2.4 kg/m2) (2). The Ethical Committee at Karolinska
Institutet approved protocols. Myoblasts were left to proliferate in
growth medium (F12/DMEM, 25 mM glucose; no. 31331; Thermo
Fisher Scientific), supplemented with 100 U/mL penicillin, 100
g/mL of streptomycin, and 0.25 g/mL of amphotericin B and 20%
FBS. Cells were used between passage 6 and 9. Differentiation to
myotubes was induced in DMEM with GlutaMAX (no. 31966; Gibco)
containing 20% medium 199 (no. 31150; Gibco), HEPES buffer (0.02
M; no. 15630; Gibco), zinc sulfate (0.03 g/mL), vitamin B12 (1.4
g/mL; Sigma-Aldrich), insulin (10 g/mL; Actrapid; Novo Nor-
disk), and apo-transferrin (100 g/mL; no. T100-5; BBI Solutions).
After 4 days, cells were switched to postfusion medium containing
DMEM/M199, HEPES, zinc sulfate, vitamin B12, and 2% FBS for 2
days. Cells were used for experiments 6–10 days after the initiation of
differentiation. Differentiation was monitored under the microscope,
and the absence of mycoplasma contamination was routinely con-
firmed by PCR.
Proliferation. Myoblasts were seeded in 25 cm2 flasks and left to
adhere and stabilize for 24 h. Five pictures of randomly chosen fields
were taken every 24 h for 72 h on an inverted light microscope.
Measurement of the surface occupied by cells was done using ImageJ
(NIH, Bethesda, MD). Script is available on request. Results are the
average of 5 independent experiments for C2C12, 5 independent
experiments for L6 and 7 replicates from 7 individuals donors for
HSMC.
Bromodeoxyuridine incorporation. L6, C2C12, and primary human
myoblasts were seeded in 96-well plates at densities of 10,000, 5,000,
and 2,500 cells/well, respectively. Cells were then incubated with 10
M bromodeoxyuridine for 12 h or 24 h, and the incorporation was
measured according to the manufacturer’s protocol (BrdU Cell Pro-
liferation Assay Kit; no. 6813; Cell Signaling Technology). Results
are the average of 6 independent experiments for C2C12, 6 indepen-
dent experiments for L6 and 6 replicates from 3 individuals donors for
HSMC.
Immunocytochemistry. Myotubes were washed with PBS, fixed in
4% paraformaldehyde for 10 min, and quenched with 0.1 M glycine
for 10 min at room temperature. After membrane permeabilization
with 0.1% Triton X-100 for 3 min, cells were washed with PBS,
blocked with 1% BSA for 15 min at room temperature, and incubated
with anti-myosin (MYH1/2; sc-53088; Santa Cruz Biotechnology) or
anti-desmin (ab15200; Abcam) antibodies (1:250) overnight at 4°C
with gentle rocking. Cells were next washed with PBS and incubated
with Alexa Fluor 594 goat anti-mouse (A-11005) or Alexa Fluor 488
goat anti-rabbit (A-11008) secondary antibodies (1:500; Thermo
Fisher Scientific), respectively, for 45 min in the dark at room
temperature. Images were acquired using 20 magnification on a
Zeiss Axio Vert.A1 inverted fluorescent microscope, equipped with
ZEN software (Carl Zeiss Microscopy GmbH, Jena, Germany).
Lactate measurement. Lactate was measured in supernatant me-
dium using a colorimetric assay, based on the conversion of lactate to
pyruvate by lactate dehydrogenase (4). Assay buffer contained Tris
(50 mM, pH 8), NAD (7.5 mM), N-methylphenazonium methyl
sulfate (250 M), p-iodonitrotetrazolium violet (500 M), and lactate
dehydrogenase (4 U/mL). Cell supernatant was filtered through 3 kDa
filters and 50 L of sample were mixed with 150 L of assay buffer,
incubated for 20 min; and absorbance was read at 490 nm. Results
were normalized to the protein content measured after lysis of the
cells with 0.03% SDS (BCA Protein Assay Kit; no. 23225; Thermo
Fisher Scientific, Rockford, IL). Results are the average of 5 inde-
pendent experiments for C2C12, 5 independent experiments for L6
and 5 replicates from 4 individual donors for HSMC.
Glucose uptake. After 2– 4 h serum starvation in low-glucose
DMEM (5.5 mM glucose; no. 21885; Gibco), myotubes were
incubated in the absence or presence of insulin (100 nmol/L) for 20
min for L6 and C2C12 and 60 min for primary human myotubes.
Glucose uptake was measured in glucose- and serum-free DMEM
(no. 11966; Gibco) by adding 2-[1,2-3H]deoxy-D-glucose (1
mCi/mL and 80.7 Ci/mmol; MT911; Moravek) and 10 mol/L
unlabeled 2-deoxy-D-glucose for 15 min. Cell monolayers were
washed with ice-cold PBS and lysed in 1 mL 0.03% SDS. The cell
lysate (0.5 mL) was counted in a liquid scintillation counter
(WinSpectral 1414; Wallac), and protein content was measured for
normalization of results (BCA Protein Assay Kit; no. 23225;
Thermo Fisher Scientific, Rockford, IL). Results are the average of
11 independent experiments for C2C12, 13 independent experi-
ments for L6 and 11 replicates from 11 individual donors for
HSMC.
C616 COMPARATIVE PROFILING OF MUSCLE MODELS
AJP-Cell Physiol • doi:10.1152/ajpcell.00540.2019 • www.ajpcell.org
Downloaded from journals.physiology.org/journal/ajpcell at Univ of Aberdeen (139.133.007.099) on June 18, 2020.
Electrical pulse stimulation. Differentiated myotubes were sub-
jected to electrical pulse stimulation (EPS; C-Pace EP; Ionoptix, MA)
at 40 V, 2 ms, 1 Hz during 3 h in low-glucose DMEM. RNA was
extracted immediately and analyzed by quantitative PCR (qPCR), as
described below. For glucose uptake, after 2 h stimulation, a solution
of 1 mCi/mL 2-[1,2-3H]deoxy-D-glucose and 10 mol/L unlabeled
2-deoxy-D-glucose was added to the medium. Glucose uptake was
measured during the last hour of EPS. Cells were washed, lysed, and
subjected to scintillation counting, as described above. Results are the
average of 6 independent experiments for C2C12, 7 independent
experiments for L6 and 7 replicates from 7 individual donors for
HSMC.
Glycogen synthesis. After 2–4 h serum starvation in low-glucose
DMEM, myotubes were treated with 100 nM insulin for 30 min before
adding 1 L D-[U-14C] glucose (1 mCi/mL and 250 mCi/mmol; no.
NEC042B005MC; PerkinElmer, Waltham, MA) for the last 90 min.
Cell monolayers were washed with ice-cold PBS and lysed in 0.5 mL
0.03% SDS. The cell lysate (0.4 mL) was transferred to 2 mL tubes,
and 0.1 mL (2 mg/sample) carrier glycogen (no. G0885; Merck) was
added. The remaining cell suspension was used for protein concen-
tration determination using the Pierce BCA Protein Assay Kit. The
samples were heated to 99°C for 1 h. Glycogen was precipitated by
addition of 95% ethanol and incubated overnight at20°C. Glycogen
pellets were collected by centrifugation for 15 min at 10,000 g,
washed once with 70% ethanol, and resuspended in 0.3 mL distilled
water. [14C]-labeled glycogen was counted in a liquid scintillation
counter and normalized to protein content. Results are the average of
9 independent experiments for C2C12, 8 independent experiments for
L6 and 12 replicates from 12 individual donors for HSMC.
Fatty acid oxidation. Myotubes were serum starved for 1 h in
DMEM (5.5 mM glucose) and then incubated for 6 h in 1 mL
low-glucose DMEM containing 25 M of palmitate, including
0.078 M [9,10-3H(N)] palmitate (5 mCi/mL and 53.7 Ci/mmol;
NET043005MC; PerkinElmer) and 0.04% BSA. Supernatant was
collected and incubated with 0.8 mL of charcoal buffer (10%
activated charcoal in 0.02 M Tris-HCl buffer at pH 7.5) and shaken
for 30 min. Samples were centrifuged (13,000 g, 15 min), and 0.2
mL of the supernatant was counted in a liquid scintillation counter.
Cells were harvested in 0.03% SDS for protein content determi-
nation using the bicinchoninic acid (BCA) protein assay. Results
are the average of 11 independent experiments for C2C12, 17
independent experiments for L6 and 37 replicates from 12 indi-
vidual donors for HSMC.
Glucose oxidation. Myotubes were serum starved for 1–2 h in
DMEM (5.5 mM glucose), and then 1 mL serum-free DMEM con-
taining 5.5 mM glucose and 2 mCi/mL D-[U-14C] glucose in the
absence or presence of 0.5 M carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP) was added to each well. A small, empty cup
was carefully added on the medium in each well before sealing the
wells with a plastic seal and incubating them for 4 h at 37°C in 0%
CO2. [14C]-CO2 was then released from the medium by injecting 150
L 2 M HCl to the medium and captured by adding 300 L 2 M
NaOH to the cup and incubating the plates for 1 h at 37°C in 0% CO2.
The [14C]-CO2 in 300 L NaOH was counted using a liquid scintil-
lation counter. Cells were harvested in 0.4 mL 0.5 M NaOH, pH was
neutralized with 0.1 mL 2 M HCl, and protein content was determined
by a BCA Protein Assay. Results are the average of 6 independent
experiments for C2C12, 8 independent experiments for L6 and 19
replicates from 12 individual donors for HSMC.
Oxygen consumption and extracellular acidification rate (Seahorse).
To assess mitochondrial function of myotubes, cells were subjected to
a Seahorse XF Mito Stress Test using the manufacturer’s instructions
(Agilent, Santa Clara, CA). The Seahorse assay media was XF Base
Media (no. 102353; Agilent, Santa Clara, CA), supplemented with 10
mM glucose, 1 mM sodium pyruvate, 2 mM glutamine, and pH
adjusted to 7.4. Cells were seeded at 30,000 cells/well (20,000
cells/well for L6 and C2C12) in 24-well, assay-specific plates. Wells
were washed, and differentiation media were added within 18 h of
seeding. After differentiation, oxygen consumption rates (OCRs) and
extracellular acidification rates (ECARs) were measured at three time
points under unstimulated conditions and then after treatment with 1
M oligomycin, 2 M FCCP, and 0.75 M rotenone/antimycin A.
Results are the average of 7 independent experiments for C2C12, 8
independent experiments for L6 and 13 replicates from 8 individual
donors for HSMC.
RNA extraction and analysis. Cultured muscle cells were lysed, and
RNA was extracted using the E.Z.N.A. Total RNA Kit (Omega
Bio-tek, Norcross, GA), and concentration was determined through
spectrophotometry. All equipment, software, and reagents for per-
forming the reverse transcription and qPCR were from Thermo Fisher
Scientific. cDNA synthesis was performed from ~0.1–1 g of RNA
using random hexamers and the High Capacity cDNA Reverse Tran-
scription Kit, according to the manufacturer’s instructions. qPCR was
performed on a StepOnePlus system. Probe sequences are available on
request. Relative gene expression was calculated by the comparative
threshold cycle (Ct) method using 18S, B2M, or TBP as house-
keeping genes. Results are the average of 6 independent experiments
for C2C12, 6 independent experiments for L6 and 5 replicates from 5
individual donors for HSMC.
Statistics. Analyses were performed using either R 3.5.2 (www.r-
project.org) or GraphPad Prism 8.1 software (GraphPad Software
Inc.). Normality was verified using the Shapiro-Wilk test. When data
were normally distributed, ANOVA with Tukey’s multiple compari-
son was used. For data not normally distributed, a Kruskal-Wallis test
with Dunn’s multiple comparison was used. Sample size and statis-
tical tests are described in figure captions.
RESULTS
Transcriptomic differences between mouse, rat, and human
skeletal muscle myotubes and tissues. Public databases were
mined for transcriptomic studies of mouse C2C12, rat L6, and
human primary myotubes, as well as skeletal muscle tissue sam-
ples collected from the same transcriptomic platforms (Supple-
mental Table S1; see https://doi.org/10.5281/zenodo.1246757).
After quality control, normalization, and annotation with the
official human gene names (Fig. 1A), we observed a clear clus-
tering of cell models and skeletal muscle tissues away from each
other (Fig. 1B). The best correlations of transcript expression were
observed between cells and tissues from the same species (e.g.,
mouse tissue vs. C2C12), suggesting important species-specific
differences in skeletal muscle mRNA composition (Fig. 1C).
Significant correlations emerged when comparing cell models
with each other or with tissues from different species, highlighting
differences between in vivo and in vitro models. When comparing
the top 100 expressed genes, we observed a significant overlap
between models (Fig. 1D). Overall, we found that genes ex-
pressed in the different cells and tissue models clustered into three
categories: genes similarly expressed in cells and adult tissues but
differentially expressed in mouse, rat, and human species, such as
the glutamate ionotropic receptor N-methyl-D-aspartate type 2B
(GRIN2B; Fig. 2A); genes expressed similarly across species but
different in cells compared with adult tissue, such as the D isoform
of lactate dehydrogenase (LDHD; Fig. 2B); and genes both dif-
ferent in cells compared with tissue and across species, such as
phospholamban (PLN; Fig. 2C).
Gene ontology enrichment comparing the three cellular
models revealed that rat L6 cells were enriched with pathways
related to metabolism and proliferation, but genes related to
muscle function and contraction were lowly expressed com-
pared with other cell models (Fig. 2D). In contrast, primary
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human cells [human skeletal muscle cells (HSMCs)] had high
levels of genes related to muscle development but a limited
number of genes related to metabolic pathways. Mouse C2C12
cells were not particularly rich in metabolism-related genes but
had increased levels of muscle-related pathways compared
with L6 and HSMC cells. Collectively, our transcriptomic
study reveals that the selective gene profiles of C2C12, L6 and
HSMC cells in vitro can be attributed to both species differ-
ences and model-specific uniqueness, potentially affecting the
response of the cells to proliferation, contraction, and meta-
bolic stimuli.
Proliferative differences. Gene ontology analysis suggested
that L6 cells might be more proliferative than C2C12 and
HSMC cells, which was confirmed by increased expression of
the proliferation marker MKI67 in L6 myotubes (Fig. 3A).
Quantification of the total cell area of myoblasts evaluated
every 24 h for 72 h revealed that L6 and C2C12 myoblasts
proliferate much faster than HSMCs (Fig. 3B). The average
doubling time calculated from an exponential (Malthusian)
growth fit was 76  26 h for HSMC, 14  6 h for C2C12, and
15  2 h for L6 myoblasts (Fig. 3C). Correspondingly, the
incorporation of bromodeoxyuridine was higher in L6 versus
HSMC (Fig. 3D).
A differentiation time course was established for each
model. HSMC, C2C12, and L6 reached maximal differentia-
tion after 4 days in culture (Fig. 3, E–G). The differential status
of HSMC and C2C12 remained stable for up to 10 days in
culture, but L6 myotubes showed a decrease in myogenic
differentiation 1 (MYOD1) and creatine kinase M type (CKM)
after 6 days in culture (Fig. 3G). For subsequent analysis, cells
were used at similar differentiation states.
Glucose uptake and glycogen synthesis. Insulin-induced glu-
cose uptake into skeletal muscle is fundamental for the regu-
lation of postprandial glycemia. Gradient-driven baseline glu-
Fig. 1. Transcriptomic profiling of rat L6, mouse C2C12, and human primary myotubes. Publicly available data sets for mouse, rat, and human skeletal muscle
tissue and cell models were downloaded from the Gene Expression Omnibus (GEO) repository. A: raw data were processed, normalized, and annotated according
to the official human gene ortholog nomenclature. B: principal component (PC) analysis demonstrated a clear segregation of all samples from each other. C:
correlation matrix comparing all transcripts from one model to the other five. D: chord diagram presenting the overlap of the top 100 expressed genes in each
model. The thickness of a band is proportional to the number of common genes between 2 models. RMA, robust multi-array.
C618 COMPARATIVE PROFILING OF MUSCLE MODELS
AJP-Cell Physiol • doi:10.1152/ajpcell.00540.2019 • www.ajpcell.org
Downloaded from journals.physiology.org/journal/ajpcell at Univ of Aberdeen (139.133.007.099) on June 18, 2020.
cose uptake in skeletal muscle is facilitated by GLUT1
(SLC2A1) in adult tissue and GLUT3 (SLC2A3) in embryonic
muscle (43). L6 myotubes expressed relatively low levels of
SLC2A1 (Fig. 4A), while HSMCs had high expression of
SLC2A3 (Fig. 4B). This functionally translated into L6 myo-
tubes having the lowest baseline glucose uptake (Fig. 4C).
GLUT4 (SLC2A4) is the only insulin-dependent glucose trans-
porter present in skeletal muscle and is translocated to the
plasma membrane upon activation of the canonical insulin
signaling cascade (22). L6 myotubes exhibited the highest
levels of SLC2A4 (Fig. 4D), and the delta subunit of phospha-
tidylinositol-4,5-bisphosphate 3-kinase (PIK3CD; Fig. 4E),
suggesting that they are more responsive to insulin. Indeed,
maximal insulin-stimulated glucose uptake in L6 cells was
increased by 1.8-fold (Fig. 4F), and this effect was higher than
C2C12 cells (1.3-fold) and HSMCs (1.2-fold).
Skeletal muscle stores glucose in the form of glycogen
during feeding periods in response to the activation of
glycogen synthase (GS). Adult skeletal muscle mainly ex-
presses the glycogen synthase 1 isoform (GYS1), while liver
relies on glycogen synthase 2 (GYS2) (14). HSMC cells had
the highest expression of GYS1 (Fig. 4G), whereas GYS2
content was low in all three cell models (Fig. 4H). Baseline
glycogen synthesis did not differ between the cell models
(Fig. 4I).
Glycogen synthase, a key enzyme in glycogen synthesis, is
activated by the allosteric stimulator glucose-6-phosphate (7)
and by dephosphorylation via the protein kinase B (PKB/Akt)
and glycogen synthase kinase 3 (GSK3) pathway (12). L6
myotubes had the lowest expression of both the alpha (GSK3A;
Fig. 4J) and beta (GSK3B; Fig. 4K) isoforms of GSK3, but the
insulin-stimulated glycogen synthesis in L6 cells (1.8-fold)
was not different from the other myotube models (Fig. 4L).
HSMC cells had the greatest fold increase in insulin-stimulated
glycogen synthesis (2.1-fold), which was higher compared
with C2C12 cells (1.6-fold).
Substrate oxidation. Skeletal muscle is a metabolically flex-
ible organ, able to switch from carbohydrate to fatty acid
Fig. 2. Gene enrichment in L6, C2C12, and human primary myotubes. A: example of a gene (GRIN2B) exhibiting species differences. B: example of a gene
(LDHD) differentially expressed in cells compared with skeletal muscle tissue. C: example of a gene (PLN) which expression is affected by both species and
cell/tissue sample. D: gene ontology enrichment of genes differentially expressed in one model compared with the other two (false discovery rate  0.05). Gene
ratio is the number of significantly different genes divided by the total number of genes associated with a specific pathway. eIF2, eukaryotic translation initiation
factor 2; HSMC, human skeletal muscle cells; p.adjust, adjusted P value.
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oxidation depending on whole-body energy demands. Under in
vitro conditions, cells rely heavily on anaerobic glycolysis,
even in the presence of oxygen and fatty acids, in a manner
similar to the Warburg effect observed in cancer cells (52). L6,
C2C12, and HSMC cells exhibited similar mRNA levels of
enzymes of the glycolysis pathway (Supplemental Table S2;
see https://doi.org/10.5281/zenodo.1246757), but HSMC had
higher mRNA expression of lactate dehydrogenase B (Fig. 5, A
and B). The extracellular acidification rate (ECAR) was similar
between the models during the 100 min of the Seahorse assay
(Fig. 5C), but accumulation of lactate in the medium over 24 h
was higher in HSMC compared with L6 and C2C12 cells (Fig.
5D). The mRNA levels of proteins involved in the mitochon-
drial respiratory chain were higher in L6 compared with
C2C12 and HSMC cells (Fig. 5E), which translated into higher
rates of oxygen consumption in L6 cells (Fig. 5F). Overall, the
L6 cells had higher metabolic rates and primarily relied on
aerobic metabolism, while C2C12 and HSMC cells relied on
anaerobic glycolysis (Fig. 5G).
Differences in oxygen consumption may be attributed to the
use of either glucose or fatty acids by the mitochondria. To
derive substrate preference, we separately measured glucose
and fatty acid oxidation using radiolabeled substrates. Fatty
acid oxidation at baseline was similar in the three models (Fig.
5H). Baseline glucose oxidation was lowest in HSMC cells
(Fig. 5I). The uncoupling agent trifluoromethoxy carbonylcya-
nide phenylhydrazone increased glucose oxidation to a similar
extent in all models (FCCP; Fig. 5J).
Structural and contractile differences. HSMC, L6 and
C2C12 cells exhibited striking differences in mRNA profiles of
actin and myosin isoforms, with ACTC1, MYH1, and MYL2
enriched in human myotubes, whereas ACTA2 and MYL1
mRNA was highest in C2C12 cells, and MYLPF mRNA was
highest in L6 myotubes (Fig. 6A). After differentiation, C2C12
and HSMC cultures exhibited long, thin myotubes that were
uniformly aligned, while L6 cultures formed a disorganized
network of thick myotubes (Fig. 6B). Desmin staining was
similar in all three cell types, but HSMC and C2C12 exhibit a
clearer expression of myosin in fully differentiated myotubes
(Fig. 6B). Overall, a monolayer of C2C12 myotubes had the
highest protein content compared with L6 and HSMC cells
(Fig. 6C).
Electrical pulse stimulation leads to sarcomere reorganiza-
tion and actual contraction of C2C12 myotubes (15), and to a
lesser extent, primary human myotubes (23) can readily be
observed. L6 myotubes do not, however, exhibit any obvious
Fig. 3. Proliferation rates of L6, C2C12, and human primary myotubes. A: mRNA expression of the proliferation marker MKI67. B: total area covered by cells
during 3 days of proliferation. Quantification of images was done with ImageJ, as described in METHODS. Mean  SE, Exponential (Malthusian) growth fit; n
totals are as follows: HSMC: n 	 7 replicates from 7 independent donors, C2C12: n 	 5 independent experiments, L6: n 	 5 independent experiments, *P 
0.05 in human skeletal muscle cells (HSMC) compared with L6 and C2C12. C: doubling time calculated from the proliferation curves. Box-and-whisker Tukey
plot; n totals are as follows: HSMC: n 	 7 replicates from 7 independent donors, C2C12: n 	 5 independent experiments, L6: n 	 5 independent experiments,
Kruskal-Wallis test with Dunn’s multiple comparison, *P  0.05. D: BrdU incorporation into DNA measured as described in METHODS. Box-and-whisker Tukey
plot; n totals are as follows: HSMC: n 	 6 replicates from 3 independent donors, C2C12: n 	 6 independent experiments, L6: n 	 6 independent experiments,
one-way ANOVA with Tukey’s multiple comparison, *P  0.05. E–G: differentiation time course of mRNA expression of skeletal muscle markers creatine
kinase (CKM), myogenin (MYOG), myogenic differentiation 1 (MYOD1), and myogenic factor 5 (MYF5). Mean SE, Dot plot; n totals are as follows: HSMC:
n 	 5 replicates from 5 independent donors, C2C12: n 	 4 independent experiments, L6: n 	 4 independent experiments, paired one-way ANOVA with
Dunnett’s multiple testing, *P  0.05 compared with undifferentiated cells. A.U., arbitrary units.
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contractile activity (26). Contraction-induced glucose uptake in
skeletal muscle depends on the activation of Ca2
/calmodulin-
dependent protein kinase II (CamKII), Rac1, and the GTPase-
activating protein for the Rab family protein TBC1D1 (46).
TBC1D1 is similarly abundant in all three cell models (Fig.
6D), but L6 myotubes had lower amounts of CAMK2A and
RAC1 mRNA (Fig. 6, E and F). Despite these differences,
electrical pulse stimulation increased glucose uptake in all cell
models with rates of EPS-stimulated glucose uptake higher in
C2C12 versus HSMC (Fig. 6G). Exercise-induced gene ex-
pression can be reproduced with EPS in vitro by measuring
specific exercise-responsive genes (13). EPS-induced tran-
scription differed slightly across the models; HSMC had higher
expression of JUNB and NR4A3 mRNA (Fig. 6H), whereas
HMOX1 mRNA induction was greater in L6 compared with
C2C12 and HSMC cells in response to EPS (Fig. 6I).
DISCUSSION
Cellular models are vital tools to study biology in controlled
environments, providing mechanistic insight into the molecular
pathways and cellular responses involved in healthy and path-
ological states. Mouse C2C12, rat L6, and human primary
myotubes are widely used in vitro models of skeletal muscle,
each with strengths and limitations that have been thoroughly
characterized in the present study. We identified important
transcriptomic and metabolic differences between C2C12, L6,
and human primary cells that arise from both species and
intrinsic divergence across cell models.
C2C12 and human primary myotubes are enriched in mRNA
of genes encoding contractile proteins. Compared with L6
myotubes, mouse C2C12 and human primary myotubes are
enriched in genes linked to muscle development and contrac-
tion, which is associated with elongated myotubes and a higher
abundance of myosin. Primary human cells exhibit the highest
levels of MYH7 and MYL2, proteins associated with type I
fibers, while C2C12 myotubes have the highest expression of
MYH1 and MYH4, proteins associated with type II (glycolytic)
fibers (41). Fiber-type composition varies greatly across spe-
cies, with rodent skeletal muscle consisting predominantly of
2X and 2B fibers and human skeletal muscle consisting of type
1 and 2A fibers (41). Thus the rodent origin of C2C12 and L6
cells may contribute to differences in myosin composition
compared with HSMC cells. C2C12 cells have been inten-
sively used to study effects of in vitro contraction on gene
expression and metabolism, using either electrical pulse stim-
ulation or manipulating calcium signaling (18, 31, 32, 42). The
higher abundance of contractile proteins in C2C12 cells, as
well as the better response to EPS-induced glucose uptake,
confirms that they are a superior model for contraction studies
than HSMC and L6 cells. However, the mRNA level of genes
encoding contractile proteins in all cell models was much
lower than fully developed adult tissue (Supplemental Table
S2; see https://doi.org/10.5281/zenodo.1246757). The precise
mechanism for this difference is unknown but may be related
to the lack of innervation, vascularization, hormonal factors,
and cellular crosstalk in cells, as these factors are required for
skeletal muscle development and repair (38). Denervation in
animal models or spinal cord injury in humans leads to skeletal
muscle atrophy and a sharp decrease in contractile protein
content and metabolism (24), but skeletal muscle satellite cells
Fig. 4. Insulin-induced glucose uptake and glycogen synthesis in L6, C2C12,
and human primary myotubes. A and B: mRNA expression of glucose trans-
porter 1 and 3 (SLC2A1 and SLC2A3). C: basal glucose uptake, as measured
using 2-[1,2-3H]deoxy-D-glucose. Box-and-whisker Tukey plot; n totals are as
follows: HSMC: n 	 11 replicates from 11 independent donors, C2C12: n 	
11 independent experiments, L6: n 	 13 independent experiments, one-way
ANOVA with Tukey’s multiple comparison. D and E: mRNA expression of
glucose transporter 4 (SLC2A4) and the delta subunit of phosphatidylinositol
3-kinase (PIK3CD). F: insulin-stimulated glucose uptake, as measured using
2-[1,2-3H]deoxy-D-glucose. Means SE and individual data points: n totals
are as follows: HSMC: n	 11 replicates from 11 independent donors, C2C12:
n 	 11 independent experiments, L6: n 	 13 independent experiments,
one-way ANOVA with Tukey’s multiple comparison. G and H: glycogen
synthase (GS) mRNA expression [GS 1 isoform (GYS1) and GS 2 isoform
(GYS2)]. I: basal glycogen synthesis, as measured by the incorporation of
[14C]glucose into glycogen. Box-and-whisker Tukey plot; n totals are as
follows: HSMC: n 	 12 replicates from 12 independent donors, C2C12: n 	
9 independent experiments, L6: n 	 8 independent experiments, Kruskal-
Wallis test with Dunn’s multiple comparison. J and K: glycogen synthase
kinase 3 (GSK3) mRNA expression. L: insulin-stimulated glycogen synthesis
as measured by the incorporation of [14C]glucose into glycogen. Means SE
and individual data points; n totals are as follows: HSMC: n 	 12 replicates
from 12 independent donors, C2C12: n 	 9 independent experiments, L6: n 	
8 independent experiments, one-way ANOVA with Tukey’s multiple compar-
ison, *P  0.05, **P  0.01, ***P  0.001. HSMC, human skeletal muscle
cells.
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retain their differentiation ability (39). Coculture with neurons
in vitro promotes differentiation of muscle cells into striated
fibers that are able to contract spontaneously (3), demonstrat-
ing the importance of innervation in skeletal muscle differen-
tiation. The absence of innervation in cultured cells likely
keeps the myocyte in an immature state.
L6 myotubes have the highest insulin-induced glucose
uptake. The coordinated action of multiple tissues is required
for whole-body fuel homeostasis, but insulin-mediated blood
glucose clearance is primarily accounted for by skeletal muscle
(49). Maintenance of skeletal muscle insulin sensitivity and
metabolic flexibility, through healthy diet and exercise, pre-
vents or delays the development of type 2 diabetes (9). Thus
exercise is an effective therapeutic intervention to combat
metabolic diseases, thereby placing skeletal muscle biology at
the core of metabolic research. Our transcriptomic profiling
revealed that L6 myotubes have low mRNA expression of the
glucose transporters GLUT1 and GLUT3 but the highest ex-
Fig. 5. Oxygen consumption and substrate use in L6, C2C12, and human primary myotubes. A and B: mRNA expression of lactate dehydrogenase subunits
(LDHA, LDHB). C: extracellular acidification rate (ECAR) during a Mito Stress Test measured with Seahorse technology. Means SE; n totals are as follows:
HSMC: n 	 13 replicates from 8 independent donors, C2C12: n 	 7 independent experiments, L6: n 	 8 independent experiments, two-way ANOVA with
Tukey’s multiple comparison. D: lactate accumulation in the extracellular medium measured as described in METHODS. Box-and-whisker Tukey plot; n totals are
as follows: HSMC: n 	 5 replicates from 4 independent donors, C2C12: n 	 5 independent experiments, L6: n 	 5 independent experiments, one-way ANOVA
with Tukey’s multiple comparison, *P 0.05, **P 0.01. E: mRNA expression of mitochondrial complexes. F: oxygen consumption rate (OCR) during a Mito
Stress Test measured with Seahorse technology. Means SE; n totals are as follows: HSMC: n 	 13 replicates from 8 independent donors, C2C12: n 	 7
independent experiments, L6: n 	 8 independent experiments, two-way ANOVA with Tukey’s multiple comparison, *P  0.05 compared with both C2C12 and
human skeletal muscle cells (HSMC), †P  0.05 compared with C2C12 and L6. G: energy plot from the Mito Stress Test. H: unstimulated fatty acid oxidation,
measured by the oxidation of [3H]palmitate into H2O. Box-and-whisker Tukey plot; n totals are as follows: HSMC: n	 37 replicates from 12 independent donors,
C2C12: n 	 11 independent experiments, L6: n 	 17 independent experiments, one-way ANOVA with Tukey’s multiple comparison. I: basal glucose oxidation
as measured by the oxidation of [14C]glucose into CO2. Box-and-whisker Tukey plot; n totals are as follows: HSMC: n 	 19 replicates from 12 independent
donors, C2C12: n 	 6 independent experiments, L6: n 	 8 independent experiments, one-way ANOVA with Tukey’s multiple comparison, *P  0.05. J:
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP)-stimulated [14C]glucose oxidation. Means SE and individual data points; n totals are as
follows: HSMC: n 	 19 replicates from 12 independent donors, C2C12: n 	 6 independent experiments, L6: n 	 7 independent experiments, one-way ANOVA
with Tukey’s multiple comparison, †P  0.05 effect of FCCP vs. unstimulated. OXPHOS, oxidative phosphorylation.
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pression of GLUT4. In vivo, GLUT1 and GLUT3 are ubiqui-
tously expressed and responsible for baseline glucose uptake.
This altered pattern of GLUT expression in cultured cells
versus muscle tissue is not an unexpected finding, since
GLUT3 is abundant in human fetal muscle, which shares
similarities with muscle cells in culture (43). In human adult
muscle, GLUT3 is enriched in slow-twitch muscle fibers com-
pared with fast-twitch fibers (44). The distribution of SLC2A3
(GLUT3) mRNA in mouse tissue is more restricted than in
human tissues, with expression essentially confined to the brain
(30). These data align with the reduced GLUT3 mRNA within
C2C12 and L6 myotubes compared with HSMC cells. Insulin-
stimulated glucose uptake depends on glucose transporter 4
(GLUT4), which is most abundant in mature mammalian
adipose, and muscle cells (19, 54). In this regard, L6 myotubes
have a pattern of GLUT expression closer to fully differenti-
ated mammalian muscle, with high levels of GLUT4 and
relatively low expression of GLUT1 and GLUT3. This pattern
Fig. 6. Response to electrical pulse stimulation (EPS) in L6, C2C12, and human primary myotubes. A: mRNA levels of myosin and actin isoforms. B:
representative images of myotubes during proliferation and after complete differentiation. Staining for desmin and myosin was performed using specific
antibodies as described in METHODS. Representative images are shown for each staining. C: protein content per well measured by bicinchoninic acid assay.
Box-and-whisker Tukey plot; n totals are as follows: HSMC: n 	 11 replicates from 11 independent donors, C2C12: n 	 7 independent experiments, L6: n 	
6 independent experiments, Kruskal-Wallis test with Dunn’s multiple comparison. D–F: mRNA levels of the GTPase-activating protein for Rab family protein
TBC1D1, Ca2
/calmodulin-dependent protein kinase II (CAMK2A), and RAC1. G: electrical pulse stimulation-induced glucose uptake measured using
2-[1,2-3H]deoxy-D-glucose. Mean  SE and individual data points: n totals are as follows: HSMC: n 	 7 replicates from 7 independent donors, C2C12: n 	
6 independent experiments, L6: n 	 7 independent experiments, one-way ANOVA with Tukey’s multiple comparison. H and I: mRNA expression of
exercise-responsive genes measured by quantitative PCR. Box-and-whisker Tukey plot; n totals are as follows: HSMC: n 	 5 replicates from 5 independent
donors, C2C12: n 	 6 independent experiments, L6: n 	 6 independent experiments, two-way ANOVA with Fisher’s least-significant difference comparison.
#P  0.05, significant response to EPS. *P  0.05. HSMC, human skeletal muscle cells.
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of GLUT expression is consistent with our observation that L6
myotubes have the lowest rate of basal glucose uptake but the
highest insulin-induced response, making them a valuable tool
for metabolic studies.
In muscle cells in vivo, most of the glucose sequestered
during rest is stored in the form of glycogen. This process is
thought to be dependent on the inhibitory phosphorylation of
GSK3 by PKB/Akt downstream of the insulin receptor (33). In
response to insulin, primary human myotubes have the highest
rate of glycogen synthesis (2.1-fold). Insulin-induced glycogen
synthesis in L6 myotubes increased by 1.8-fold, despite the fact
that GSK3 is lowly expressed, consistent with observations of
similar glycogen content in mice with inactive GSK3 com-
pared with wild-type mice (7). Collectively, these results sug-
gest that allosteric regulation of glycogen synthase by glucose-
6-phosphate plays a critical role in the insulin-stimulated syn-
thesis of glycogen in L6 myotubes, as reported for mouse
skeletal muscle in vivo (8).
Human primary myotubes have the lowest oxidative capacity.
Skeletal muscle fibers are rich in mitochondria, the activity of
which is required to sustain ATP production via oxidative
phosphorylation. Within skeletal muscle tissue, the oxidative
fibers have particularly high mitochondrial content, and the
capacity for oxidative phosphorylation provides resistance to
fatigue (28). From the cell types tested in this study, HSMCs
have the highest mRNA expression of GLUT3, citrate synthase
(Supplemental Table S2; see https://doi.org/10.5281/zenodo.
1246757), and myosin heavy chains associated with type I
fibers (41), suggesting that these cells better represent adult
oxidative fibers compared with L6 and C2C12 cells. However,
the oxygen consumption rate of HSMC cells is paradoxically
lower than all other muscle cell types tested. Reduced mito-
chondrial content and activity are observed in type 2 diabetes,
physical inactivity, and aging in vivo (16, 21, 48), suggesting
that HSMC cells in vitro possess lower mitochondrial content
and/or dysfunctional mitochondria compared with muscle cells
in their physiological environment.
Oxygen consumption was the highest in L6 myotubes com-
pared with C2C12 and HSMC cells, despite our finding that
these cells have the lowest basal glucose uptake. Curiously,
baseline glucose uptake, substrate oxidation, and oxygen con-
sumption were not correlated with each other. Fatty acid
oxidation rates were similar in the three cell models, but
glucose oxidation was substantially different. The glucose
oxidation assay measures CO2 released from glucose, making
it a proxy of TCA cycle activity, whereas the lipid oxidation
and Seahorse assays estimate mitochondrial oxidative phos-
phorylation. These metabolic assays suggest that L6 cells have
the most robust coupling between glucose uptake and oxidative
phosphorylation. HSMCs divert glucose to glycolysis, while
C2C12 likely diverts glucose from the TCA cycle to amino
acid synthesis (5, 40). This finding may be related to the
relatively high abundance of mRNA coding for contractile pro-
teins in C2C12 and HSMC cells with L6 cells, which would
require enhanced TCA cycle activity to support amino acid
synthesis. Overall, our data demonstrate that L6, C2C12 and
HSMC cells have a fundamentally different metabolism and may
divert substrates into selective pathways based on the need for
protein synthesis or energy.
Conclusion. Our study provides experimental evidence that
rat L6, mouse C2C12, and human primary myotubes exhibit
profoundly different transcriptomic profiles and metabolic be-
haviors (Fig. 7). L6 myotubes are more suitable for studies of
glucose metabolism and mitochondrial function, while C2C12
and primary human myotubes resemble differentiated muscle



























Fig. 7. Schematic representation of C2C12, L6, and human primary myotube metabolic pathways. Fatty acid oxidation was similar in all three cell models;
therefore changes in glucose metabolism between the cell types may explain the differences in metabolism across models. Human primary myotubes have the
highest baseline glucose uptake and lactate production, suggesting that these cells rely mostly on glycolysis for energy production. On the other end of the
spectrum, L6 myotubes have a relatively lower baseline glucose uptake, but these cells oxidize most of the intracellular glucose in the mitochondria. C2C12 cells
have moderate rates of glucose uptake, with intracellular glucose directed toward the TCA cycle. Oxidative phosphorylation and TCA coupling to oxidative
phosphorylation are greater in L6. The thickness of the arrows and the size of text represent the intensity of the corresponding pathways compared with the other
models. HSMC, human skeletal muscle cells.
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may be more appropriate for studies of exercise/stress re-
sponses. These cell-specific and tissue-specific responses are
dependent on the unique transcriptomic profile of each system.
This transcriptomic plasticity is presumably conferred by the
transformed nature of L6 and C2C12, the variability in human
donors for the HSMC, and epigenetics that are influenced by
many factors, such as differences in batches of fetal bovine
serum, growth and counting of passages, and the heteroge-
neous storage conditions of cells over several decades between
laboratories. Our study establishes the utility of each cellular
system to model adult skeletal muscle and provides an evi-
dence-based rationale to consider when selecting either L6,
C2C12, or human primary cells to explore developmental and
metabolic processes in skeletal muscle.
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